Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CFTR | P13569 | 1/20 | 0.48 |
| ▸ | GOPC | Q9HD26 | 1/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 2/20 | 0.38 |
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | GAA | P10253 | 3/20 | 0.38 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | LMNA | P02545 | 3/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.36 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | ESR1 | P03372 | 1/20 | 0.36 |
| ▸ | TP53 | P04637 | 1/20 | 0.36 |
| ▸ | TYMS | P04818 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30074263 | 1.00 | CFTR (0.48) | CFTRGOPCKDM4EPOLBNPC1 | |
| SCHEMBL6552460 | 0.90 | ESR1 (0.51) | CFTRGOPCKDM4EPOLBGAA | |
| SCHEMBL6550908 | 0.90 | CFTR (0.41) | CFTRGOPCKDM4EPOLBNPC1 | |
| Propionic Acid SCHEMBL4796324 | 0.87 | PKM (0.41) | CFTRGOPCKDM4EGAANPSR1 | |
| SCHEMBL6550929 | 0.86 | MAPT (0.46) | CFTRGOPCNPC1NPSR1SMN1; SMN2 | |
| SCHEMBL28609498 | 0.85 | PGR (0.38) | CFTRGOPCPOLBLMNASMN1; SMN2 | |
| SCHEMBL28606394 | 0.85 | MDM2 (0.40) | CFTRGOPCPOLBNPSR1LMNA | |
| SCHEMBL14462993 | 0.85 | S100A4 (0.42) | CFTRGOPCPOLBHSP90AA1SMN1; SMN2 | |
| SCHEMBL28610336 | 0.81 | NPSR1 (0.57) | CFTRGOPCPOLBGAANPSR1 | |
| SCHEMBL28357232 | 0.80 | MAPT (0.44) | CFTRGOPCKDM4EPOLBGAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 223 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-109180446-A | A kind of synthetic method of 2,3- diphenyl -1H- 1-Indanone derivative | 吉林化工学院 | 2019-01-11 | — | — | CN | claimed |
| US-20020004519-A1 | METHOD FOR REDUCING CHLORIDE SECETION BY INTESTINAL EPITHLIAL CELLS IN SITU | LENCER WAYNE I (US) | 2002-01-10 | — | — | US | claimed |
| JP-2001523717-A | — | — | 2001-11-27 | — | — | JP | claimed |
| EP-1032385-A1 | USE OF SUBSTITUTED DIPHENYL INDANONE, INDANE AND INDOLE COMPOUNDS FOR THE TREATMENT OR PREVENTION OF SICKLE CELL DISEASE, INFLAMMATORY DISEASES CHARACTERIZED BY ABNORMAL CELLPROLIFERATION, DIARRHE AND SCOURS | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2000-09-06 | — | — | EP | claimed |
| WO-1999026624-A1 | USE OF SUBSTITUTED DIPHENYL INDANONE, INDANE AND INDOLE COMPOUNDS FOR THE TREATMENT OR PREVENTION OF SICKLE CELL DISEASE, INFLAMMATORY DISEASES CHARACTERIZED BY ABNORMAL CELL PROLIFERATION, DIARRHE AND SCOURS | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1999-06-03 | — | — | WO | claimed |
| EP-4263544-B1 | INDOLO[3.2.1-JK]CARBAZOLE-6-CARBONITRILE DERIVATIVES AS BLUE EMITTERS IN OLEDS | UDC IRELAND LTD (IE) | 2026-05-13 | — | — | EP | disclosed |
| US-12628554-B2 | Photoelectric conversion element, imaging element, optical sensor, and compound | FUJIFILM CORPORATION (JP) | 2026-05-12 | — | — | US | disclosed |
| US-12568754-B2 | Laminate comprising a wavelength-conversion material and a wavelength-selective absorption layer, display device, and organic electroluminescent display device | FUJIFILM CORPORATION (JP) | 2026-03-03 | — | — | US | disclosed |
| EP-4676208-A2 | NITROGEN-CONTAINING HETERO-AROMATICS FOR ORGANIC ELECTROLUMINESCENT DEVICES | Merck Patent GmbH (DE) | 2026-01-07 | — | — | EP | disclosed |
| US-20250393473-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, AND OPTICAL SENSOR | FUJIFILM CORP (JP) | 2025-12-25 | — | — | US | disclosed |
| US-20250374741-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, OPTICAL SENSOR, AND COMPOUND | FUJIFILM CORP (JP) | 2025-12-04 | — | — | US | disclosed |
| US-12479989-B2 | Wavelength selective absorption filter and organic electroluminescent display device | FUJIFILM CORPORATION (JP) | 2025-11-25 | — | — | US | disclosed |
| EP-1047411-A1 | SUBSTITUTED DIPHENYL INDANONE, INDANE AND INDOLE COMPOUNDS AND ANALOGUES THEREOF USEFUL FOR THE TREATMENT OR PREVENTION OF DISEASES CHARACTERIZED BY ABNORMAL CELL PROLIFERATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-11-02 | — | — | EP | disclosed |
| EP-1047411-A1 | SUBSTITUTED DIPHENYL INDANONE, INDANE AND INDOLE COMPOUNDS AND ANALOGUES THEREOF USEFUL FOR THE TREATMENT OR PREVENTION OF DISEASES CHARACTERIZED BY ABNORMAL CELL PROLIFERATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2000-11-02 | — | — | EP | disclosed |
| EP-1032385-A1 | USE OF SUBSTITUTED DIPHENYL INDANONE, INDANE AND INDOLE COMPOUNDS FOR THE TREATMENT OR PREVENTION OF SICKLE CELL DISEASE, INFLAMMATORY DISEASES CHARACTERIZED BY ABNORMAL CELLPROLIFERATION, DIARRHE AND SCOURS | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2000-09-06 | — | — | EP | disclosed |
| EP-1032385-A1 | USE OF SUBSTITUTED DIPHENYL INDANONE, INDANE AND INDOLE COMPOUNDS FOR THE TREATMENT OR PREVENTION OF SICKLE CELL DISEASE, INFLAMMATORY DISEASES CHARACTERIZED BY ABNORMAL CELLPROLIFERATION, DIARRHE AND SCOURS | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 2000-09-06 | — | — | EP | disclosed |
| WO-1999026611-A1 | SUBSTITUTED DIPHENYL INDANONE, INDANE AND INDOLE COMPOUNDS AND ANALOGUES THEREOF USEFUL FOR THE TREATMENT OR PREVENTION OF DISEASES CHARACTERIZED BY ABNORMAL CELL PROLIFERATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1999-06-03 | — | — | WO | disclosed |
| WO-1999026624-A1 | USE OF SUBSTITUTED DIPHENYL INDANONE, INDANE AND INDOLE COMPOUNDS FOR THE TREATMENT OR PREVENTION OF SICKLE CELL DISEASE, INFLAMMATORY DISEASES CHARACTERIZED BY ABNORMAL CELL PROLIFERATION, DIARRHE AND SCOURS | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1999-06-03 | — | — | WO | disclosed |
| WO-1999026624-A1 | USE OF SUBSTITUTED DIPHENYL INDANONE, INDANE AND INDOLE COMPOUNDS FOR THE TREATMENT OR PREVENTION OF SICKLE CELL DISEASE, INFLAMMATORY DISEASES CHARACTERIZED BY ABNORMAL CELL PROLIFERATION, DIARRHE AND SCOURS | CHILDREN'S MEDICAL CENTER CORPORATION (US) | 1999-06-03 | — | — | WO | disclosed |
| WO-1999026611-A1 | SUBSTITUTED DIPHENYL INDANONE, INDANE AND INDOLE COMPOUNDS AND ANALOGUES THEREOF USEFUL FOR THE TREATMENT OR PREVENTION OF DISEASES CHARACTERIZED BY ABNORMAL CELL PROLIFERATION | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 1999-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12568754-B2 | Laminate comprising a wavelength-conversion material and a wavelength-selective absorption layer, display device, and organic electroluminescent display device | STRA6, CDH1, EPCAM | CFTR 4149/4885GOPC 1845/4885KDM4E 657/4885 |
| US-20020004519-A1 | METHOD FOR REDUCING CHLORIDE SECETION BY INTESTINAL EPITHLIAL CELLS IN SITU | SLC10A2, VIP, SLC26A3 | CFTR 128/4885GOPC 2332/4885KDM4E 1852/4885 |
| US-20250393473-A1 | PHOTOELECTRIC CONVERSION ELEMENT, IMAGING ELEMENT, AND OPTICAL SENSOR | NR2E3, CRY1, CRY2 | CFTR 1746/4885GOPC 3162/4885KDM4E 2101/4885 |
| US-12628554-B2 | Photoelectric conversion element, imaging element, optical sensor, and compound | SCO2, CRY2, PYM1 | CFTR 2708/4885GOPC 983/4885KDM4E 2716/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.